National Cancer Institute

Goodwin to manufacture ADC for Aspyrian

Goodwin to manufacture ADC for Aspyrian

By Zachary Brennan

Aspyrian Therapeutics has selected CDMO Goodwin Biotechnology to complete process development, scale-up, and cGMP manufacturing of their novel antibody drug conjugate (ADC).